Niels Janssen

Niels Janssen

Company: Roche

Job title: Group Head DMPK/PD


Development of Next Generation CNS Drugs: Trontinemab, an Anti-Amyloid Beta Brainshuttle Antibody 3:15 pm

Developing “Brainshuttle”, a versatile platform to enhance brain delivery of therapeutic proteins and other cargos across the blood brain barrier via receptor mediated transcytosis Showcasing translational strategies and learnings from the Brainshuttle antibody fusion trontinemab: The journey from mice to patients, towards a new generation of Amyloid beta lowering therapiesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.